Steatohepatitis/Metabolic Liver Disease News

A multidisciplinary nonalcoholic fatty liver disease approach effectively improved liver-related and cardiovascular risk factors, according to research presented at The Digital International Liver Congress.

For healthy patients, miR-34a may be a reliable biomarker to effectively rule-out nonalcoholic fatty liver disease, according to research presented at The Digital International Liver Congress.

The annual risk for cirrhosis based on liver stiffness criteria was 7% among patients with nonalcoholic fatty liver disease enriched with nonalcoholic steatohepatitis, according to research presented at The Digital International Liver Congress.

Investigators have recently published ample data from several nonalcoholic steatohepatitis studies.

Nonalcoholic fatty liver disease was independently linked to recurrent atrial fibrillation after AF ablation, according to findings published in JACC: Clinical Electrophysiology.

Aldafermin decreased liver fat and trended toward fibrosis improvement among patients with non-alcoholic steatohepatitis, according to a study published in Gastroenterology.

There are many people in the United States living with viral hepatitis, which can lead to liver health problems such as nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

An aerobic exercise program may help improve histologic endpoints in patients with metabolic dysfunction associated fatty liver disease, according to study results.

Standard of care lifestyle counseling correlated with improvements in nonalcoholic steatohepatitis or fibrosis in half of the children with nonalcoholic fatty liver, according to study results publish in Gastroenterology.

Perspectum announced it will evaluate the use of LiverMultiScan as a diagnostic tool to identify eligible patients for enrollment into nonalcoholic steatohepatitis clinical trials.